About CAR-T leukemia therapy, part of a new wave in cancer treatment – ABC News
Chicago Tribune |
About CAR–T leukemia therapy, part of a new wave in cancer treatment
ABC News The committee's approval for CAR–T therapy applies to children and young adults, ages 3 to 25, with a form of leukemia called relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). ALL is the most common type of cancer in children, with … First gene therapy — 'a true living drug' — on the cusp of FDA approval Novartis CAR–T Therapy Drug Recommended by FDA Panel FDA may approve goundbreaking cancer treatment that uses body's immune system to fight disease |
